Interstitial lung disease and nephritis, which are frequently observed during treatment with mTOR inhibitors in solid organ transplant recipients and cancer patients, may be another clues indicating relationship between mTOR pathway and EMT (Figure 1A) [6,7]. The gene discussed is MTOR; the disease is interstitial lung disease.